Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress

Obesity

Volumn 16, Issue 10, 2008, Pages 2232-2238

  Thomàs Moyà, Elena ^a,b   Gómez Pérez, Yolanda ^a,b   Fiol, Miguel ^b,c   Gianotti, Magdalena ^a,b   Lladó, Isabel ^a,b   Proenza, Ana M ^a,b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTIOXIDANT; APOLIPOPROTEIN A; ARYLDIALKYLPHOSPHATASE; CLU PROTEIN, RAT; CLUSTERIN; INSULIN; LIPID; LIPID PEROXIDE; MESSENGER RNA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; BLOOD; CALORIC INTAKE; COMPARATIVE STUDY; DISEASE MODEL; EATING; ENZYMOLOGY; FAT INTAKE; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION; RAT; SEX DIFFERENCE; TIME; WEIGHT GAIN; WISTAR RAT;

ADIPOKINES; ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS A; ARYLDIALKYLPHOSPHATASE; BLOOD GLUCOSE; CLUSTERIN; DIETARY FATS; DISEASE MODELS, ANIMAL; EATING; ENERGY INTAKE; FEMALE; INSULIN; LIPID PEROXIDES; LIPIDS; LIVER; MALE; OBESITY; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; RNA, MESSENGER; SEX FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; WEIGHT GAIN;

RATTUS; RATTUS NORVEGICUS;

EID: 53849132335     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.340     Document Type: Article

References (55)

1. Levin BE. Factors promoting and ameliorating the development of obesity. Physiol Behav 2005;86:633-639.
2. Rothwell NJ, Stock MJ. Regulation of energy balance in two models of reversible obesity in the rat. J Comp Physiol Psychol 1979;93:1024-1034.
3. Llado I, Rodriguez-Cuenca S, Pujol E et al. Gender effects on adrenergic receptor expression and lipolysis in white adipose tissue of rats. Obes Res 2002;10:296-305.
4. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
5. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288:H2031-H2041.
6. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
7. Mutlu-Turkoglu U, Oztezcan S, Telci A et al. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med 2003;2:171-174.
8. Myara I, Alamowitch C, Michel O et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 2003;11:112-120.
9. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478.
10. Mertens A, Verhamme P, Bielicki JK et al. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003;107:1640-1646.
11. Ferretti G, Bacchetti T, Moroni C et al. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 2005;90:1728-1733.
12. Kelso GJ, Stuart WD, Richter RJ et al. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry 1994;33:832-839.
13. Gaidukov L, Tawfik DS. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry 2005;44:11843-11854.
14. Watson AD, Berliner JA, Hama SY et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882-2891.
15. Shih DM, Xia YR, Wang XP et al. Combined serum paraoxonase knockout/ apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 2000;275:17527-17535.
16. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69:541-50.
17. Aviram M, Rosenblat M, Billecke S et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.
18. Thomas-Moya E, Gianotti M, Llado I, Proenza AM. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity. J Nutr Biochem 2006;17:197-203.
19. Thomas-Moya E, Gianotti M, Proenza AM, Llado I. Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med 2007;13:203-209.
20. Thomas-Moya E, Gianotti M, Proenza AM, Llado I. The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats. J Lipid Res 2006;47:2042-2048.
21. Moreira EA, Fagundes RL, Filho DW et al. Effects of diet energy level and tomato powder consumption on antioxidant status in rats. Clin Nutr 2005;24:1038-1046.
22. Milagro FI, Campion J, Martinez JA. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 2006;14:1118-1123.
23. Llado I, Estrany ME, Rodriguez E et al. Effects of cafeteria diet feeding on beta3-adrenoceptor expression and lipolytic activity in white adipose tissue of male and female rats. Int J Obes Relat Metab Disord 2000;24:1396-1404.
24. Mackness B, Durrington PN, Mackness MI. Lack of protection against oxidative modification of LDL by avian HDL. Biochem Biophys Res Commun 1998;247:443-446.
25. Pickavance LC, Buckingham RE, Wilding JP. Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia. Diabetes Obes Metab 2001;3:171-180.
26. Umeda M, Kanda T, Murakami M. Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats. Hypertens Res 2003;26:485-492.
27. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
28. Aebi HE. Catalase. In Bergmeyer HU (ed.) Methods in enzymatic analysis. Verlag Chemie, Basel. 1984, 273-286.
29. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
30. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-490.
31. Quick KL, Hardt JI, Dugan LL. Rapid microplate assay for superoxide scavenging efficiency. J Neurosci Methods 2000;97:139-144.
32. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. Biochem J 1971;123:823-828.
33. Ferre N, Camps J, Prats E et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem 2002;48:261-268.
34. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
35. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-excel-based tool using pair-wise correlations. Biotechnol Lett 2004;26:509-15.
36. Sorenson RC, Bisgaier CL, Aviram M et al. Human serum Paraoxonase/ Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol 1999;19:2214-2225.
37. Oda MN, Bielicki JK, Berger T, Forte TM. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. Biochemistry 2001;40:1710-1718.
38. Lopez IP, Marti A, Milagro FI et al. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 2003;11:188-194.
39. Gianotti M, Roca P, Palou A. Body weight and tissue composition in rats made obese by a cafeteria diet. Effect of 24 hours starvation. Horm Metab Res 1988;20:208-212.
40. Ruiz-Gutierrez V, Perez-Espinosa A, Vazquez CM, Santa-Maria C. Effects of dietary fats (fish, olive and high-oleic-acid sunflower oils) on lipid composition and antioxidant enzymes in rat liver. Br J Nutr 1999;82:233-241.
41. Ruiz-Gutierrez V, Vazquez CM, Santa-Maria C. Liver lipid composition and antioxidant enzyme activities of spontaneously hypertensive rats after ingestion of dietary fats (fish, olive and high-oleic sunflower oils). Biosci Rep 2001;21:271-285.
42. Demori I, Voci A, Fugassa E, Burlando B. Combined effects of high-fat diet and ethanol induce oxidative stress in rat liver. Alcohol 2006;40:185-191.
43. Kriska T, Marathe GK, Schmidt JC, McIntyre TM, Girotti AW. Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides. J Biol Chem 2007;282:100-108.
44. Thomas-Moya E, Nadal-Casellas A, Gianotti M, Llado I, Proenza AM. Time-dependent modulation of rat serum paraoxonase 1 activity by fasting. Pflugers Arch 2007;453:831-837.
45. Coatmellec-Taglioni G, Dausse JP, Giudicelli Y, Ribiere C. Gender difference in diet-induced obesity hypertension: implication of renal alpha2-adrenergic receptors. Am J Hypertens 2002;15:143-149.
46. Coatmellec-Taglioni G, Dausse JP, Giudicelli Y, Ribiere C. Sexual dimorphism in cafeteria diet-induced hypertension is associated with gender-related difference in renal leptin receptor down-regulation. J Pharmacol Exp Ther 2003;305:362-367.
47. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 1999;29:758-769.
48. Yamagishi SI, Edelstein D, Du XL et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276:25096-25100.
49. Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003;170:21-29.
50. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38.
51. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-581.
52. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999;13:1231-1238.
53. Bajnok L, Csongradi E, Seres I et al. Relationship of adiponectin to serum paraoxonase 1. Atherosclerosis 2007;197:363-367.
54. Ferretti G, Bacchetti T, Negre-Salvayre A et al. Structural modifications of HDL and functional consequences. Atherosclerosis 2006;184:1-7.
55. Nguyen SD, Sok DE. Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochem J 2003;375:275-285.